Purpose: Beam matching occurs on all linacs to some degree and when two are more are matched to each other, patients are able to be transferred between machines.
standard plans on all the linacs. 8 The study showed that matching a new linac to a reference linac does not guarantee that it is matched to the established treatment planning model. Similarly, Gersgjevitsh et al. 9 demonstrated that a single TPS model could not be supported by their three Elekta linacs which were matched according to the vendor's beam matching criteria, calling for stricter criteria and an additional subset of dosimetric data to be matched to if a single model was to be used. Alternatively, a study by Swamy et al., like
Sjöström et al., also considered "fine beam-matched" Varian linacs and found that from delivery of fifteen volumetric modulated arc therapy (VMAT) plans, the standard deviation in gamma (2%/2 mm) pass rates was 1.00%, demonstrating excellent beam matching in terms of VMAT delivery. 10 To date there have not been any studies published considering beam matching for stereotactic body radiotherapy (SBRT) and the tighter tolerances and objectives it might require, so the feasibility of distributive QA and treatment delivery of SBRT should thus be assessed and verified.
Stereotactic body radiotherapy describes extracranial treatment techniques which utilize a larger delivery of radiation dose than conventional radiotherapy and in fewer fractions resulting in a higher biological effective dose for the treatment site. 11 The hypofraction- 15 These plans were sent to the respective record and verify systems for treatment.
The spine case included four VMAT arcs with 120 control points per arc and a prescription of 30 Gy in three fractions to the planned target volume and a maximum dose to the spinal cord of 18 Gy. 16 A transverse slice of the original plan is shown in Fig. 1 respectively. All gamma analyses in this study were performed through absolute dose comparison with a global γ calculation and a 10% low dose cut-off threshold. 18 Global normalization was used as it has been deemed more relevant than local normalization for QA of clinical cases. Both spine and lung cases passed ArcCheck and film QA on all machines tested according to routine clinical methods and recommended tolerances (>90% pass rate at 3%/2 mm). 19 The suggested gamma criteria of 3%/2 mm was used as the reference criterion for comparison between linacs for both film and ArcCheck. An example of a film dose comparison for the spine case assessed at 3%/2 mm is shown in Fig. 3 where the difference in dose gradient between delivered and planned (5.42%/mm) dose can be observed.
QA results are listed in Table 3 for mean gamma pass rates, CNS dose differences and dose gradients. The CNS dose difference was taken as the point dose difference between the TPS and measured doses at the centre of the CNS contour. The CNS dose is important in terms of myelopathy risk 20 while varying degrees of PTV coverage may be more acceptable to the clinician in terms of accepted protocols and reference trials. 15, 21, 22 The dose gradient has been recorded in % dose per millimetre in accordance with similar studies. 23 The mean values for all four metrics were certainly adequate and standard deviations small, demonstrating excellent beam matching in terms of SBRT delivery.
More sensitive DTA of 3%/1.5 mm and 3%/1 mm were used in 
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CNS doses for the spine case also show good agreement amongst the linac sample with a difference to planned dose of 2.51% ± 1.62%. In an absolute sense, this also satisfies the recommendations of Palta et al. where the action limit for low dose, low gradient regions is up to 7%. 24 All target doses were within 5% of planned. [25] [26] [27] Aside from the CNS dose, the dose drop off between target and spinal cord is one of the most important aspects of SBRT spine QA. The variation in dose gradient was also found to be very | 103 plane while ArcCheck attempts to gain an appreciation of the total dose fluence. The two QA methods also differ in accuracy on a few levels. Film receives a higher maximum dose so is less sensitive to low dose differences (when using global comparison), suffers from processing and calibration uncertainties but has a higher resolution (scanned at 75 DPI) and can show where dose differences will likely occur anatomically. ArcCheck receives a lower maximum dose due to the fluence washout so is arguably more sensitive in regions with low dose fluence, can detect angular dependent fluence errors, has lower uncertainty in dose calibration but also has a lower resolution Interestingly, Table 2 shows that the profile flatnesses are not tightly grouped about the baseline value, making use of their 1% wiggle room. This appears to have little effect on the QA results, perhaps for the sole reason that the test cases involved small, isocentric fields where profiles become increasingly indistinguishable, even between flattened and unflattened fields. Even for nonisocentric plans, the 3% dose difference criterion would not be sensitive enough to detect these profile differences. This then puts greater emphasis in the accuracy of the machine's MLC calibration and dose output.
In addition to the tests described here, other parameters need to be tighter than for regular treatments 30 For a department that wishes to beam match their linear accelerator fleet to a degree beyond VMAT that allows for distributive QA and delivery of SBRT, the following items are recommended:
1. Profiles and PDDs should be matched to criteria that is stricter than vendor guidelines. 9 For example, the linacs in this study 6. If the SBRT workload is light, then regular testing of each machine through a standard complex SBRT case should be performed to observe any drift in MLC calibration.
7.
Daily output and imaging checks should be performed during run-up or otherwise to capture any gross differences on the day of treatment.
| CONCLUSION
A study of complex SBRT lung and spine cases was conducted through delivery and quality assurance on nine beam matched linacs in order to assess the feasibility of a distributive approach to SBRT QA and delivery. The results of this study suggest that at recommended gamma criterion the delivery accuracy of the SBRT cases is well-matched between machines and well above the recommended gamma pass rates, with differences in pass rates at stricter criteria attributed to MLC discrepancies. While both film and ArcCheck are informative in the benchmarking process, film should always be used for QA of clinical plans. Distributive QA and delivery of SBRT is thus feasible but requires initial beam matching of machines at stricter criteria than recommended by manufacturers as well as an ongoing QA program that also includes assessments of other parameters like image guidance.
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